Back
American Express Co. Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison
Buy
69
AXP
American Express Co.
Last Price:
$376.40
Seasonality Move:
5.39%
Sell
18
RARE
Ultragenyx Pharmaceutical, Inc.
Last Price:
$33.50
Seasonality Move:
-0.96%
Buy
69
American Express Co. (AXP)
is a Buy
Is American Express Co. a Buy, Sell or Hold?
-
The current American Express Co. [AXP] share price is $375.52. The Score for AXP is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
AXP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
18
Ultragenyx Pharmaceutical, Inc. (RARE)
is a Sell
Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?
-
The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $32.84. The Score for RARE is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
-
RARE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
AXP Stock Price Chart
What is American Express Co.'s stock price today?
-
The American Express Co. share price today is $375.52The current trend is moderately bullish and AXP is experiencing selling pressure, which indicates risk of future bearish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical, Inc.'s stock price today?
-
The Ultragenyx Pharmaceutical, Inc. share price today is $32.84Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
AXP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.39 | Buy |
| Relative Strength Index (14 RSI): | 58.1 | Buy |
| Chaikin Money Flow: | -1444397 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (351.6 - 376.98) | Buy |
| Bollinger Bands (100): | (315.01 - 363.73) | Buy |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.67 | Buy |
| Relative Strength Index (14 RSI): | 41.45 | Sell |
| Chaikin Money Flow: | -1089594 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.6 - 35.94) | Sell |
| Bollinger Bands (100): | (29.09 - 34.15) | Buy |
AXP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 377.67 | Sell |
| 20-day SMA: | 367.94 | Buy |
| 50-day SMA: | 358.14 | Buy |
| 200-day SMA: | 312.57 | Buy |
| 8-day EMA: | 376.21 | Sell |
| 20-day EMA: | 370.21 | Buy |
| 50-day EMA: | 358.85 | Buy |
| 200-day EMA: | 323.38 | Buy |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.17 | Sell |
| 20-day SMA: | 34.68 | Sell |
| 50-day SMA: | 33.7 | Sell |
| 200-day SMA: | 33.61 | Sell |
| 8-day EMA: | 13.04 | Buy |
| 20-day EMA: | 5.99 | Buy |
| 50-day EMA: | 2.54 | Buy |
| 200-day EMA: | 0.65 | Buy |
American Express Co. Earnings Growth & AXP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.89 per share, and an increase next year of $2.01 per share.
Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.
American Express Co. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||